Contact Us News RSS Login

Harvard Catalyst - The Harvard Clinical and Translational Science Center
  1. People
    1. Overview
    2. Grant Central
    3. Medvane
    4. Profiles
  2. Learning
    1. Overview
    2. Colloquium Series
    3. Conferences and Seminars
    4. Dean's Symposium
    5. Leder Human Biology
    6. Biomedical Informatics Training
    7. Biostatistics Training
    8. Clinical Investigator Training Program
    9. Scholars in Clinical Science
    10. KL2 Medical Research Investigator Training
    11. Introduction to Clinical Investigation
    12. Biostatistics Seminar Series
    13. Genetics Courses
    14. Imaging Courses
  3. Resources
    1. Overview
    2. Pilot Funding
    3. AEGIS Influenza
    4. Atlas
    5. Community-Based Participatory Research
    6. Community Connect to Research
    7. Consulting Programs
    8. Core Facilities
    9. HarvardTrials
    10. Health Disparities Research Program
    11. In/Outpatient Resources
    12. Laboratory for Innovative Translational Technologies
    13. Law and Health Policy
    14. Medications and Society
    15. Pathology Specimen Locator
    16. SHRINE
    17. Webdash
Find
People

Profiles

Read About Profiles -- the Harvard Catalyst's social networking site.
Find information about people's institutions in the Atlas.

Dianne Madelyn Finkelstein, PH.D.

  Back
Title
Professor in the Department of Biostatistics
Institution
School of Public Health
Department
Biostatistics
Address
Massachusetts General Hospital
Biostatistics Center, Ste 560
50 Staniford Street
Boston, MA 02114
Telephone
617/726-5970
Fax
617/724-9878
Email
Email Address
Other Positions
Title
Professor of Medicine
Institution
Massachusetts General Hospital
Department
Medicine
Division
Hematology/Oncology
Publications
1. Shannon KM, Lubratovich ML, Finkelstein DM, Smith BL, Powell SN, Seiden MV. Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center. Cancer. 2002 Jan 15; 94(2):305-13.
2. DiRienzo AG, van Der Horst C, Finkelstein DM, Frame P, Bozzette SA, Tashima KT. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. AIDS Res Hum Retroviruses. 2002 Jan 20; 18(2):89-94.
3. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol. 2002 Feb 15; 20(4):1063-8.
4. Betensky RA, Finkelstein DM. Testing for dependence between failure time and visit compliance with interval-censored data. Biometrics. 2002 Mar; 58(1):58-63.
5. Finkelstein DM, Goggins WB, Schoenfeld DA. Analysis of failure time data with dependent interval censoring. Biometrics. 2002 Jun; 58(2):298-304.
6. Hodi FS, Soiffer RJ, Clark J, Finkelstein DM, Haluska FG. Phase II study of paclitaxel and carboplatin for malignant melanoma. Am J Clin Oncol. 2002 Jun; 25(3):283-6.
7. Ettinger DS, Finkelstein DM, Ritch PS, Lincoln ST, Blum RH. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588). Lung Cancer. 2002 Sep; 37(3):311-8.
8. Pauler DK, Finkelstein DM. Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes. Stat Med. 2002 Dec 30; 21(24):3897-911.
9. Pierie JP, Choudry U, Muzikansky A, Finkelstein DM, Ott MJ. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg. 2003 Jan; 196(1):45-50.
10. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003 Jun 5; 348(23):2285-93.
11. Finkelstein DM, Muzikansky A, Schoenfeld DA. Comparing survival of a sample to that of a standard population. J Natl Cancer Inst. 2003 Oct 1; 95(19):1434-9.
12. Ancukiewicz M, Finkelstein DM, Schoenfeld DA. Modelling the relationship between continuous covariates and clinical events using isotonic regression. Stat Med. 2003 Oct 30; 22(20):3151-9.
13. Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol. 2005 Mar 1; 23(7):1507-13.
14. Tyminski E, Leroy S, Terada K, Finkelstein DM, Hyatt JL, Danks MK, Potter PM, Saeki Y, Chiocca EA. Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan. Cancer Res. 2005 Aug 1; 65(15):6850-7.
15. Amrein PC, Clark JR, Supko JG, Fabian RL, Wang CC, Colevas AD, Posner MR, Deschler DG, Rocco JW, Finkelstein DM, McIntyre JF. Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma. Cancer. 2005 Oct 1; 104(7):1418-27.
16. Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM. Analysis of co-aggregation of cancer based on registry data. Community Genet. 2006; 9(2):87-92.
17. Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006 Feb 20; 24(6):863-71.
18. Rajicic N, Finkelstein DM, Schoenfeld DA. Survival analysis of longitudinal microarrays. Bioinformatics. 2006 Nov 1; 22(21):2643-9.
19. Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol. 2007 May; 2(3):461-9.
20. Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, Hodin RA. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg. 2007 Apr; 142(4):381-6.
21. Matthews AG, Finkelstein DM, Betensky RA. Multivariate logistic regression for familial aggregation in age at disease onset. Lifetime Data Anal. 2007 Jun; 13(2):191-209.
22. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA. 2008 Jan 2; 299(1):53-60.
23. Bell DW, Brannigan BW, Matsuo K, Finkelstein DM, Sordella R, Settleman J, Mitsudomi T, Haber DA. Increased Prevalence of EGFR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms. Clin Cancer Res. 2008 Jul 1; 14(13):4079-84.
 
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu. SPH faculty should contact Cary Lou (clouhsph.harvard.edu).